Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C10H14BrNO2 |
| Molecular Weight | 260.128 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(CCN)=C(OC)C=C1Br
InChI
InChIKey=YMHOBZXQZVXHBM-UHFFFAOYSA-N
InChI=1S/C10H14BrNO2/c1-13-9-6-8(11)10(14-2)5-7(9)3-4-12/h5-6H,3-4,12H2,1-2H3
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Automated headspace solid-phase microextraction and in-matrix derivatization for the determination of amphetamine-related drugs in human urine by gas chromatography-mass spectrometry. | 2002 Jan |
|
| 4-Bromo-2,5-dimethoxyphenethylamine (2C-B): a review of the public domain literature. | 2002 Oct-Dec |
|
| Optimization of the separation and on-line sample concentration of phenethylamine designer drugs with capillary electrophoresis-fluorescence detection. | 2006 Jan 6 |
|
| 1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonists. | 2006 Sep 21 |
|
| Metabolism of designer drugs of abuse: an updated review. | 2010 Jun 1 |
|
| Cerebral vasculopathy after 4-bromo-2,5-dimethoxyphenethylamine ingestion. | 2010 May |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DEA NO. |
7392
Created by
admin on Fri Dec 15 19:10:20 GMT 2023 , Edited by admin on Fri Dec 15 19:10:20 GMT 2023
|
||
|
WIKIPEDIA |
Designer-drugs-2C-B
Created by
admin on Fri Dec 15 19:10:20 GMT 2023 , Edited by admin on Fri Dec 15 19:10:20 GMT 2023
|
||
|
WIKIPEDIA |
PiHKAL
Created by
admin on Fri Dec 15 19:10:20 GMT 2023 , Edited by admin on Fri Dec 15 19:10:20 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
V77772N32H
Created by
admin on Fri Dec 15 19:10:20 GMT 2023 , Edited by admin on Fri Dec 15 19:10:20 GMT 2023
|
PRIMARY | |||
|
DB01537
Created by
admin on Fri Dec 15 19:10:20 GMT 2023 , Edited by admin on Fri Dec 15 19:10:20 GMT 2023
|
PRIMARY | |||
|
66142-81-2
Created by
admin on Fri Dec 15 19:10:20 GMT 2023 , Edited by admin on Fri Dec 15 19:10:20 GMT 2023
|
PRIMARY | |||
|
2C-B
Created by
admin on Fri Dec 15 19:10:20 GMT 2023 , Edited by admin on Fri Dec 15 19:10:20 GMT 2023
|
PRIMARY | |||
|
DTXSID10216332
Created by
admin on Fri Dec 15 19:10:20 GMT 2023 , Edited by admin on Fri Dec 15 19:10:20 GMT 2023
|
PRIMARY | |||
|
100000126036
Created by
admin on Fri Dec 15 19:10:20 GMT 2023 , Edited by admin on Fri Dec 15 19:10:20 GMT 2023
|
PRIMARY | |||
|
SUB32985
Created by
admin on Fri Dec 15 19:10:20 GMT 2023 , Edited by admin on Fri Dec 15 19:10:20 GMT 2023
|
PRIMARY | |||
|
98527
Created by
admin on Fri Dec 15 19:10:20 GMT 2023 , Edited by admin on Fri Dec 15 19:10:20 GMT 2023
|
PRIMARY | |||
|
m3180
Created by
admin on Fri Dec 15 19:10:20 GMT 2023 , Edited by admin on Fri Dec 15 19:10:20 GMT 2023
|
PRIMARY | Merck Index | ||
|
189669
Created by
admin on Fri Dec 15 19:10:20 GMT 2023 , Edited by admin on Fri Dec 15 19:10:20 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE (PARENT)
PRODRUG (METABOLITE ACTIVE)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
